PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31856338-0	2020	Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration-resistant prostate cancer.	enzalutamide	49-61	Wnt family member 5A	Homo sapiens	27-30	
31856338-11	2020	This was validated by the elevated expression of noncanonical Wnt pathway members such as Wnt5a, RhoA, and ROCK in enzalutamide-resistant PCa cells in comparison to their enzalutamide-sensitive counterparts.	enzalutamide	171-183	Wnt family member 5A	Homo sapiens	62-65	
31856338-11	2020	This was validated by the elevated expression of noncanonical Wnt pathway members such as Wnt5a, RhoA, and ROCK in enzalutamide-resistant PCa cells in comparison to their enzalutamide-sensitive counterparts.	enzalutamide	171-183	Wnt family member 5A	Homo sapiens	90-95	
31856338-15	2020	CONCLUSIONS: The noncanonical Wnt pathway is activated in enzalutamide-resistant PCa and inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance and enhances its efficacy in CRPC.	enzalutamide	58-70	Wnt family member 5A	Homo sapiens	30-33	
31856338-15	2020	CONCLUSIONS: The noncanonical Wnt pathway is activated in enzalutamide-resistant PCa and inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance and enhances its efficacy in CRPC.	enzalutamide	138-150	Wnt family member 5A	Homo sapiens	30-33	
31856338-15	2020	CONCLUSIONS: The noncanonical Wnt pathway is activated in enzalutamide-resistant PCa and inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance and enhances its efficacy in CRPC.	enzalutamide	138-150	Wnt family member 5A	Homo sapiens	116-119	
31856338-10	2020	RESULTS: We found that the noncanonical Wnt signaling was activated in enzalutamide-resistant PCa cells and that the activation of noncanonical Wnt signaling was correlated with AR expression and disease progression.	enzalutamide	71-83	Wnt family member 5A	Homo sapiens	40-43	
31856338-11	2020	This was validated by the elevated expression of noncanonical Wnt pathway members such as Wnt5a, RhoA, and ROCK in enzalutamide-resistant PCa cells in comparison to their enzalutamide-sensitive counterparts.	enzalutamide	115-127	Wnt family member 5A	Homo sapiens	62-65	
31856338-11	2020	This was validated by the elevated expression of noncanonical Wnt pathway members such as Wnt5a, RhoA, and ROCK in enzalutamide-resistant PCa cells in comparison to their enzalutamide-sensitive counterparts.	enzalutamide	115-127	Wnt family member 5A	Homo sapiens	90-95